# FDA Inspection 624302 - Biotest Pharmaceuticals - October 28, 2009

Source: https://www.globalkeysolutions.net/records/fda_inspections/biotest-pharmaceuticals/e8db0641-6843-40ce-b450-8c3a4b7bf6bf
Source feed: FDA_Inspections

> FDA Inspection 624302 for Biotest Pharmaceuticals on October 28, 2009. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 624302
- Company Name: Biotest Pharmaceuticals
- Inspection Date: 2009-10-28
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1262757 - 2025-02-13](https://www.globalkeysolutions.net/records/fda_inspections/biotest-pharmaceuticals/416116f6-d28b-4423-94b4-a708e301a00e)
- [FDA Inspection 1262757 - 2025-02-13](https://www.globalkeysolutions.net/records/fda_inspections/biotest-pharmaceuticals/8eee8ab6-cf7b-45c8-b3fc-29847ceacd14)
- [FDA Inspection 1069240 - 2018-10-16](https://www.globalkeysolutions.net/records/fda_inspections/biotest-pharmaceuticals/92fceb0a-fa18-4361-8296-9f12305fa748)
- [FDA Inspection 986994 - 2016-10-05](https://www.globalkeysolutions.net/records/fda_inspections/biotest-pharmaceuticals/6cd0d815-db52-469e-b769-86c8238403c4)
- [FDA Inspection 921672 - 2015-04-09](https://www.globalkeysolutions.net/records/fda_inspections/biotest-pharmaceuticals/05666fbe-9412-4350-a388-dee19151f1f6)

Company: https://www.globalkeysolutions.net/companies/biotest-pharmaceuticals/7433d234-46a0-4680-b44d-18b57b7f363d

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d